University of Rochester Center for Health + Technology (UR CHeT)

Watch to learn what we do at the Center for Health + Technology (CHeT)!

Greetings from Montreal, Canada! CHeT is at the 15th #braininjurycongress, the largest global gathering of experts in brain injury research and rehabilitation. Exciting discussions on the latest advancements in assessment, treatment, and future priorities are underway! #IBIA2025

Wrapping up an incredible #MDAconference during MDA’s 75th anniversary year! We joined over 2,000 experts in neuromuscular research, clinical care, industry, and advocacy to discuss progress and shape the future of neuromuscular care. We're grateful for the opportunity to be part of these important conversations—see you next year! Muscular Dystrophy Association #MDA75

2nd full day at the 2025 #MDAconference! Another exciting day connecting and sharing our work with researchers, clinicians, and advocates in the neuromuscular research community. Stop by our booth if you're here! Muscular Dystrophy Association #MDA75

Kicking off the first full day at the 2025 #MDAconference in Dallas, Texas! With over 1,700 attendees and 300 vendors, it's an exciting opportunity to connect and share our work in research and clinical advancements for neuromuscular disease. Stop by our booth to say hi! Muscular Dystrophy Association #MDA75

It’s Brain Awareness Week and we’re spreading information about brain health and neurodegenerative diseases, which occur when nerve cells in the brain or peripheral nervous system lose function and ultimately die. NDs affect millions of people worldwide and there are no known cures for them. The Cures Collective works to unify the neurodegenerative disease field, accelerate finding treatments and cures, increase and improve access to care through intentional collaboration, and sustain public awareness and mobilization. Learn more at https://lnkd.in/ept3RHGR

Patients involved in clinical trials often await pivotal discoveries to treat and expand understanding of their disease, but are we truly capturing their experience? Patient reported outcomes (PROs) are vital for understanding therapeutic impact in a way that is both specific and sensitive to change. However, poorly designed PROs can burden patients and skew results. At the University of Rochester Center for Health and Technology, we prioritize patient-centered design and use an iterative approach to ensure our PROs are relevant, highly sensitive, and generate reliable data. In the end, this leads to more meaningful trial outcomes and lower patient burden. #PROs #DiseaseBurden #ClinicalTrials #HealthIndexes View CHeT PROs: https://lnkd.in/gwNrFaJz

Need a highly sensitive and responsive instrument for your spinal-bulbar muscular atrophy studies? The SBMA-HI is precision-designed for reliability and FDA regulatory compliance to measure how patients feel and function in response to treatments. Learn more: https://lnkd.in/e8Uaakwq Explore our full range of instruments: https://lnkd.in/e7vFMCTi #SpinalBulbarMuscularAtrophy #SBMA

Today is Rare Disease Day! At CHeT, we are committed to advancing research, innovation, and clinical trials that bring hope to individuals and families impacted by rare diseases. Join us in raising awareness, supporting research, and standing with the rare disease community today and every day!   #RareDiseaseDay

Exciting new research from CHeT Innovation and BioSensics published in Communications Medicine demonstrates the potential of wearable technology to monitor upper limb function in Huntington’s disease (HD). Using the PAMSys ULM sensor and machine learning, the study effectively differentiates individuals with HD, those at risk, and healthy controls, offering new possibilities for early detection, remote monitoring, and treatment evaluation in clinical trials. Read more: https://lnkd.in/e4nUXcyv